CICLOFERON

Manufacturer: MarcasUSA LLC | Laboratorios Liomont, S.A. de C.V.
Effective date: 2019-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-05-31 23:02:10

Label at a glance#

ProductCICLOFERON

Active ingredientBENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE

Label structure22 sections

Dosage and administration

clean the affected area apply a small amount of this product to the affected area 1 to 3 times daily may be covered with a sterile bandage children under 12 years of age, consult a doctor

Storage and handling

store at 20° to 25°C (68° to 77°F)

Contacts and useful links#

PhoneLabel contact1-800-428-9489

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients
Benzalkonium Chloride 0.13%
Lidocaine Hydrochloride 2%

Purpose
Topical antiseptic
Topical analgesic

OTC - PURPOSE SECTION

Uses

INDICATIONS & USAGE SECTION

provides temporary relief of pain associated with cold sores and fever blisters
first aid to help protect against infection in minor cuts, scrapes, burns

Warnings

WARNINGS SECTION

For external use only

Do not use in the eyes or apply over large areas of the body. In case of deep puncture wounds, animal bites, or serious burns, consult a doctor.

Do not use

OTC - DO NOT USE SECTION

for more than 7 days unless told to do so by a doctor
more than directed
if you are allergic to any ingredient in this product

When using this product

OTC - WHEN USING SECTION

avoid contact with the eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens
symptoms last more than 7 days or clear up and occur again within a few days
swelling, rash or fever develops

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

clean the affected area
apply a small amount of this product to the affected area 1 to 3 times daily
may be covered with a sterile bandage
children under 12 years of age, consult a doctor

Other Information

STORAGE AND HANDLING SECTION

store at 20° to 25°C (68° to 77°F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

hypromellose, methylparaben, propylene glycol, water, polysorbate 80

SPL UNCLASSIFIED SECTION

Manufactured by/Hecho en México por:
LABORATORIOS LIOMONT, S.A. DE C.V.
A. López Mateos 68. Cuajimalpa 05000
México, DF
Distributed by/Distribuido por: MarcasUSA, LLC
El Segundo, CA 90245
Questions? Call Toll-Free 1-800-428-9489
¿Preguntas? Llame Gratis al 1-800-428-9489

OTC - ACTIVE INGREDIENT SECTION

Ingredientes Activos
Cloruro de Benzalkonio 0.13%
Clorhidrato de Lidocaina 2%

Propósito
Antiséptico tópico
Analgésico tópico

Usos

OTC - PURPOSE SECTION

alivio temporal del dolor asociado con el herpes labial y ampollas de fiebre
primeros auxilios para ayudar a proteger contra la infección de cortes, raspaduras y quemaduras menores

Precauciones

WARNINGS SECTION

Sólo para uso externo:

No usar en los ojos ni aplique sobre grandes zonas de el cuerpo. En caso de heridas punzantes profundas, mordeduras de animales o quemaduras graves, consulte a un médico.

No se use

por más de 7 días a menos que así lo indique un médico
más de lo indicado
si usted es alérgico a cualquiera de los ingredientes de este producto

Al utilizar este producto

OTC - WHEN USING SECTION

evite el contacto con los ojos

Suspenda su uso y consulte a su médico si

OTC - STOP USE SECTION

la condición empeora
los síntomas no desaparecen en 7 días o reaparecen a los pocos dias
desarrolla hinchazón, comezón o fiebre

Mantener fuera del alcance de los niños.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

En caso de ingerir el producto obtenga ayuda médica o contacte a un Poison Control Center inmediatamente.

Modo de Empleo

DOSAGE & ADMINISTRATION SECTION

limpiar el área afectada
Aplique una pequeña cantidad de este producto en la área afectada de 1 a 3 veces al día
pueden ser cubiertos con un vendaje estéril
niños menores de 12 años de edad, consulte a un médico

Otra información

STORAGE AND HANDLING SECTION

mantenga a una temperatura de 20°a 25°C (68° a 77°F)

Ingredientes Inactivos

INACTIVE INGREDIENT SECTION

hipromelosa, metilparabeno, propilenglicol, agua, polisorbato 80

SPL UNCLASSIFIED SECTION

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FAST PAIN RELIEF
ALIVIO RÁPIDO DEL DOLOR

CLEAR GEL APPLIES INVISIBLE
GEL TRANSPARENTE APLICA INVISIBLE

NDC 75940-122-04

Net wt 0.14oz / Peso Neto 4g

Clear Gel

CICLOFERON^®

COLD SORE
treatment

tratamiento para
FUEGOS

Manufactured by/Hecho en México por:
LABORATORIOS LIOMONT, S.A. DE C.V.
A. López Mateos 68. Cuajimalpa 05000
México, DF

Distributed by/Distribuido por:
MarcasUSA, LLC
El Segundo, CA 90245
Questions? Call Toll-Free 1-800-428-9489
¿Preguntas? Llame Gratis al 1-800-428-9489

Container Label

2X Medicine
Cicloferon

NDC 75940-122-05

LIOMONT

0.13% benzalkonium chloride/2% lidocaine hydrochloride

COLD SORE Treatment / Tatamiento para FUEGOS

RAPIDRELIEV^TM FORMULA

Relieves Pain AND Fights Virus

INSTANT RELIEF from Pain

CLINICAL PROVEN to reduce spread of cold sores

CLEAR GEL invisible and odorless

Net wt 4g (.14 oz)

Clamshell Label

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1431687	benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]	benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]	SBD Active

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1431682	benzalkonium chloride 0.13 % / lidocaine HCl 2 % Topical Gel	PSN	7
1431687	CICLOFERON 0.13 % / 2 % Topical Gel	PSN	7
1431687	benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel [Cicloferon]	SBD	7
1431682	benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD	7
1431682	benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % Topical Gel	SY	7
1431687	Cicloferon (benzalkonium chloride 0.13 % / lidocaine hydrochloride 2 % ) Topical Gel	SY	7

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
LIDOCAINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
75940-122-02	2020-09-27	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-04	2020-09-27	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-05	2020-09-27	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-02	2020-09-25	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-04	2020-09-25	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-05	2020-09-25	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-02	2020-07-22	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-04	2020-07-22	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts
75940-122-05	2020-07-22	C162847	48780-1	ab0e2407-31c3-f274-e053-dbdaa90a6471	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
75940-122-02	CICLOFERON	1 in 1 CARTON	GEL	1	7
75940-122-02	CICLOFERON	2 g in 1 TUBE	GEL	2	7
75940-122-04	CICLOFERON	4 g in 1 TUBE	GEL	4	7
75940-122-04	CICLOFERON	1 in 1 CARTON	GEL	1	7
75940-122-05	CICLOFERON	4 g in 1 TUBE	GEL	4	7
75940-122-05	CICLOFERON	1 in 1 CONTAINER	GEL	1	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
75940-122	CICLOFERON (BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE) GEL [MARCASUSA LLC]	7	Legacy NDC, 6 package rows	20191220_e2c62b5f-56ee-4d04-9c19-26849fe2b2b1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BENZALKONIUM CHLORIDE	ACTIVE INGREDIENT	F5UM2KM3W7	5
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	5
BENZALKONIUM	ACTIVE MOIETY	7N6JUD5X6Y	5
LIDOCAINE	ACTIVE MOIETY	98PI200987	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	5
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	5
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	5
WATER	INACTIVE INGREDIENT	059QF0KO0R	5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

CICLOFERON
benzalkonium chloride and lidocaine hydrochloride
BENZALKONIUM CHLORIDE
BENZALKONIUM
LIDOCAINE HYDROCHLORIDE
LIDOCAINE
LIDOCAINE HYDROCHLORIDE ANHYDROUS
HYPROMELLOSES
METHYLPARABEN
PROPYLENE GLYCOL
WATER
POLYSORBATE 80

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
75940-122	75940-122-02, 75940-122-04, 75940-122-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BENZALKONIUM CHLORIDE	F5UM2KM3W7	ACTIB
LIDOCAINE HYDROCHLORIDE	V13007Z41A	ACTIR
HYPROMELLOSES	3NXW29V3WO	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
WATER	059QF0KO0R	IACT
POLYSORBATE 80	6OZP39ZG8H	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 265 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CREAM, AUGMENTED / TOPICAL	8 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	AEROSOL / TOPICAL	19.2 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / TOPICAL	0.24 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAMUSCULAR	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / EPIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / TOPICAL	5.28 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SOLUTION / ORAL		22602 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / TOPICAL		216 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION / ORAL		27120 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SOLUTION / ORAL		907 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL, METERED / TOPICAL		1225 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	PASTE, DENTIFRICE / DENTAL	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION, EXTENDED RELEASE / ORAL		1000 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 27 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / AURICULAR (OTIC)	0.01 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, DELAYED RELEASE / ORAL		36 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	3.6 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	8 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SYSTEM / TOPICAL		28 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	221 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GRANULE, FOR SUSPENSION / ORAL		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	PASTE / ORAL		28 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	15 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SOLUTION / OPHTHALMIC	0.5 %w/v		Exact identifier — unii candidate 27 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	DROPS / AURICULAR (OTIC)	0.02 %w/w		Exact identifier — unii candidate 78 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	GRANULE / ORAL		45 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM / BUCCAL	1.48 mg		Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PARENTERAL		18 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	GRANULE, FOR SUSPENSION / ORAL		240 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SUSPENSION/ DROPS / OPHTHALMIC	0.75 %w/v		Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SYSTEM / TOPICAL		4200 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRADERMAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRAVENOUS	0.5 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION / INTRAVENOUS		4680 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SYSTEM / TOPICAL		42 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SOLUTION/ DROPS / OPHTHALMIC	0.25 %w/v		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	SUPPOSITORY / VAGINAL	28 mg		Exact identifier — unii candidate 78 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRAMUSCULAR		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	PASTE / DENTAL	0.5 %w/w		Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	TABLET, DELAYED RELEASE / ORAL		79 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION, EXTENDED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SPRAY / NASAL		5 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SUSPENSION / INTRA-ARTICULAR		4 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	CONCENTRATE / ORAL		7000 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS		4739 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		19 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	SYRUP / ORAL		5700 mg	Exact identifier — unii candidate 81 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION / RECTAL	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / SUBCUTANEOUS	0.16 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
POLYSORBATE 80	POLYSORBATE 80	6OZP39ZG8H	CONCENTRATE / INTRAVENOUS		4680 mg	Exact identifier — unii candidate 78 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	AEROSOL, FOAM / TOPICAL	0.16 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INFILTRATION		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
HYPROMELLOSES	HYPROMELLOSE	3NXW29V3WO	SUSPENSION/ DROPS / OPHTHALMIC		3 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION/ DROPS / OPHTHALMIC	0.05 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	TABLET / ORAL		64 mg	Exact identifier — unii candidate 81 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
28277214-5f33-4222-b73b-0858aa08adc7			e2c62b5f-56ee-4d04-9c19-26849fe2b2b1	2019-12-19	Warnings	Exact identifier spl id: 28277214-5f33-4222-b73b-0858aa08adc7 spl set id: e2c62b5f-56ee-4d04-9c19-26849fe2b2b1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

CICLOFERON

Label at a glance#

Dosage and administration

Storage and handling

Contacts and useful links#

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Uses

Warnings

Do not use

When using this product

Stop use and ask a doctor if

Keep out of reach of children

Directions

Other Information

Inactive Ingredients

SPL UNCLASSIFIED SECTION

OTC - ACTIVE INGREDIENT SECTION

Usos

Precauciones

Al utilizar este producto

Suspenda su uso y consulte a su médico si

Mantener fuera del alcance de los niños.

Modo de Empleo

Otra información

Ingredientes Inactivos

SPL UNCLASSIFIED SECTION

PRINCIPAL DISPLAY PANEL

Related RxNorm Concepts#

DailyMed RxNorm Mappings#

DailyMed Pharmacologic Classes#

DailyMed Product Concepts#

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

DailyMed Dashboard NDC Coverage#

DailyMed Socrata Ingredients#

Products#

NDC Codes#

Ingredients#

Source Document#

Inactive ingredient matches#

openFDA label cross-check#

Reported adverse events (FAERS/openFDA)#